Day: December 2, 2022
Notice of redemption of convertible bonds PKG5
AS Pro Kapital Grupp informs that it is redeeming 24 500 “EEK 7.00 PRO KAPITAL GRUPP CONV. BOND PKG5 10-2020” convertible bonds (with ISINEE3300109917) in total nominal value of 245 000 Estonian kroons and issue value of 68 600 euros and has submitted the Nasdaq Central Depository of Securities the application to delete the bonds from the register.
The convertible bonds bore an annual interest of 7%. The issue price of each convertible bond was 2.80 euros. The list of bondholders was fixed on 29 November 2022 and redemption payment will be made on 13 December 2022.
Edoardo Axel Preatoni
Member of the Management Board
+372 614 4920prokapital@prokapital.ee
Notice of redemption of convertible bonds PKG5
Written by Customer Service on . Posted in Public Companies.
Notice of redemption of convertible bonds PKG5
AS Pro Kapital Grupp informs that it is redeeming 24 500 “EEK 7.00 PRO KAPITAL GRUPP CONV. BOND PKG5 10-2020” convertible bonds (with ISINEE3300109917) in total nominal value of 245 000 Estonian kroons and issue value of 68 600 euros and has submitted the Nasdaq Central Depository of Securities the application to delete the bonds from the register.
The convertible bonds bore an annual interest of 7%. The issue price of each convertible bond was 2.80 euros. The list of bondholders was fixed on 29 November 2022 and redemption payment will be made on 13 December 2022.Edoardo Axel Preatoni
Member of the Management Board
+372 614 4920prokapital@prokapital.ee
Stelmine acquires three new properties in the de Caniapiscau district
Written by Customer Service on . Posted in Public Companies.
QUEBEC CITY, Dec. 02, 2022 (GLOBE NEWSWIRE) — Stelmine Canada (« Stelmine ») (TSXV : STH). Stelmine maintains its aggressive strategy of acquiring mining properties in the Caniapiscau mining district. The Company is adding 326 new claims to his portfolio bringing the total to 1775 claims covering 936 km2. This scenario allows the Company to protect his dominant land position and develop this new district while taking advantage of high potential mineral targets.
In addition to the gold potential, the mineralization discovered on these three new properties should help Stelmine reach its objective of diversifying its portfolio and actively engage in the exploration of strategic metals such as nickel and some base metals while pursuing the advancement of its gold properties.
Undoubtedly, during the last five years, Stelmine took the...
Horizon Therapeutics plc
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1)
State Street Global Advisors & AffiliatesCompany dealt in
Horizon Therapeutics plcClass of relevant security to which the dealings being disclosed relate (Note 2)
$0.0001 ordinary sharesDate of dealing
01st Dec 2022
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Long
Short
Number
(%)
Number
(%)(1) Relevant securities
5,916,453
2.61001%
(2) Derivatives (other than options)
508
0.000224%
(3) Options and agreements to purchase/sell
N/A
N/A
Total
5,916,961
2.61024%
(b)...
Horizon Therapeutics plc
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1)
State Street Global Advisors & AffiliatesCompany dealt in
Horizon Therapeutics plcClass of relevant security to which the dealings being disclosed relate (Note 2)
$0.0001 ordinary sharesDate of dealing
29th Nov 2022
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Long
Short
Number
(%)
Number
(%)(1) Relevant securities
5,889,421
2.59809%
(2) Derivatives (other than options)
508
0.000224%
(3) Options and agreements to purchase/sell
N/A
N/A
Total
5,889,929
2.59831%
(b)...
CareCloud To Host Virtual Analyst and Investor Day
Written by Customer Service on . Posted in Public Companies.
SOMERSET, N.J., Dec. 02, 2022 (GLOBE NEWSWIRE) — CareCloud, Inc. (the “Company”) (Nasdaq: MTBC, MTBCO, MTBCP), a leader in healthcare technology solutions for medical practices and health systems nationwide, announced they will host an inaugural Analyst and Investor Day from 1 to 3 p.m. EST on Monday, December 12, 2022 using a live webcast.
CareCloud leadership team will use this virtual event to share with participants their historic vision to transform the healthcare industry through high-quality technology, world-class operations and exciting new products. For 20 years, CareCloud has been a pillar in the healthcare technology space, helping healthcare providers deliver a premium, high-value experience for every patient. The Company is at the forefront of the industry’s shift to digitization and a value-based care model, with...
Horizon Therapeutics plc
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1)
State Street Global Advisors & AffiliatesCompany dealt in
Horizon Therapeutics plcClass of relevant security to which the dealings being disclosed relate (Note 2)
$0.0001 ordinary sharesDate of dealing
28th Nov 2022
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Long
Short
Number
(%)
Number
(%)(1) Relevant securities
5,905,507
2.60519%
(2) Derivatives (other than options)
508
0.000224%
(3) Options and agreements to purchase/sell
N/A
N/A
Total
5,906,015
2.60541%
(b)...
SeaStar Medical Bolsters Operational Expertise with Appointment of Thomas R. Mullen as Vice President of Operations and Product Development
Written by Customer Service on . Posted in Public Companies.
DENVER, COLORADO, Dec. 02, 2022 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq:ICU), (“SeaStar Medical” or the “Company”), a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, today announced the appointment of Thomas R. Mullen as Vice President of Operations and Product Development. Mr. Mullen is a proven medical device professional with 30 years of experience leading business operations, manufacturing, engineering, product development and regulatory remediation.
“SeaStar Medical has continued to evolve and remains on a trajectory of growth including near-term potential for commercialization. As we continue our preparations for success in treating both acute and chronic illnesses through advanced product offerings, we believe Tom’s extensive...
HIGHCO: Shareholding as 11-30-2022
Written by Customer Service on . Posted in Public Companies.
INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Declaration pursuant to Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulations of the Autorité des marchés financiers (AMF)Date of settlementof information
Total number of shares
Number of shares without voting rights (*)
Number of voting rights for threshold calculation (**)
Number of actual voting rights (exercisable at shareholders’ meeting)November 30, 2022
20 455 403
177 280
23 012 201
22 834 921October 31, 2022
20 455 403
145 022
23 048 421
22 903 399September 30, 2022
20 455 403
90 180
23 050 521
22 960 341August 31, 2022
20 455 403
83 843
23 050 522
22 966 679July 31, 2022
20 455 403
82 029
23 050 622
22 968 593July 2, 2022 (***)
20 455 403
78 771
23 050 722
22 971 951June 30, 2022
22 421 332
2 044 700
25 016...
Skyharbour Resources Receives $895,000 from Warrant Exercises
Written by Customer Service on . Posted in Public Companies.
Vancouver, BC, Dec. 02, 2022 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (the “Company”) is pleased to announce it has received an aggregate CAD $895,027.32 from the exercise of share purchase warrants with a strike price at $0.22 since June 29th, 2022. A total of 4,068,306 warrants have been exercised with this batch of warrants expiring November 29th, 2022.
About Skyharbour Resources Ltd.:
Skyharbour holds an extensive portfolio of uranium exploration projects in Canada’s Athabasca Basin and is well positioned to benefit from improving uranium market fundamentals with fifteen projects, ten of which are drill-ready, covering over 450,000 hectares of land. Skyharbour has acquired from Denison Mines, a large strategic shareholder of the Company, a 100% interest in the Moore Uranium...